The global oral antibiotics market generated $18,365.80 million in 2018, and is projected to reach $23,306.10 million by 2027, growing at a CAGR of 2.7% from 2019 to 2027.
Antibiotic is an antimicrobial substance or a compound that fights against bacterial infections and sometimes with protozoan infections, but not viral infections. These are medications that either stop bacteria from growing or kill bacteria directly, referred as bacteriostatic and bactericidal antibiotics, respectively. There are several types of antibiotics easily available at drug stores and in hospitals with a prescription or without a prescription in most of countries. Antibiotics are mostly used during transplants, dialysis, suppressed immune system, and joint replacement.
Request Sample Copy of Oral Antibiotics Market: https://www.premiummarketinsights.com/sample/AMR00028963
- Abbott Laboratories
- Allergan Plc.
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline plc
- Merck & Co. Mylan N.V.
- Novartis International AG (Sandoz)
- Pfizer Sanofi
- Teva Pharmaceutical Industries Ltd.
There is an increase in demand for antibiotics, owing to increased consumption in low- and middle-income countries (LMICs) and rise in prevalence of infectious diseases. In addition, development of novel approaches for new antibiotics to treat bacterial infections and large number of clinical trials further drive the market growth. However, development of antibiotic resistance, driven by misuse of antibiotics and time taken for regulatory approvals are projected to impede the market growth. On the contrary, discovery of advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections are expected to offer significant profitable opportunities for the market players.
KEY MARKET SEGMENTS
– Beta Lactam and Beta Lactamase Inhibitors
– Broad Spectrum Penicillin
– Mid/Narrow Spectrum Penicillin
– Community-respiratory tract infections (CARTIS)
o Upper Respiratory Tract Infections (URTI)
o Lower Respiratory Tract Infections (LRTI)
– Urinary acquired tract infections (UTIS)
By Drug Origin
By Spectrum of Activity
– Broad-spectrum Antibiotic
– Narrow-spectrum Antibiotic
By Drug Type
Avail Discount on this [email protected]: https://www.premiummarketinsights.com/discount/AMR00028963
Critical Success Factors (CSFs)
The competitive landscape of the market has been examined on the basis of market share analysis of key players. Detailed market data about these factors is estimated to help vendors take strategic decisions that can strengthen their positions in the market and lead to more effective and larger stake in the global Oral Antibiotics Market. Pricing and cost teardown analysis for products and service offerings of key players has also been undertaken for the study.
Table of Contents:
1 Executive Summary
3 Oral Antibiotics Market Overview
4 Market Trend Analysis
5 Global Oral Antibiotics Market Segmentation
6 Market Effect Factors Analysis
7 Market Competition by Manufacturers
8 Key Developments
9 Company Profiling
About Premium market insights:
Premiummarketinsights.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Call: US: +1-646-491-9876, Apac: +912067274191
Email: [email protected]